Janux Therapeutics stock opens at double the upsized IPO's pricing

By
  Comments

Referenced Symbols

Janux Therapeutics Inc. JANX, +50.97% received a bullish reception on its Wall Street debut, as shares of the California-based biotechnology company developing cancer treatments opened at double the upsized initial public offering price before paring some gains. The company raised $193.8 million as it sold 11.4 million shares in the IPO, which priced at $17 a share. That compares with previous expectations for an offering of 9.5 million shares and a pricing of between $15 and $17 a share. The stock's first trade was at $34.00 at 10:55 a.m. Eastern for 64,588 shares, which valued the company at about $1.3 billion. The stock has pulled back some since then, but was still up 43.1% at $24.32 in recent trading. the stock's bullish debut comes on a day that the Renaissance IPO ETF IPO, +1.02% rose 0.8% while the S&P 500 SPX, +0.06% declined 0.1%.

Read Next

Read Next

Orphazyme stock's rocket ride leads to 20 volatility halts, Galecto stock halted 7 times

Shares of Orphazyme A/S undefined blasted 383.8% higher, enough to make the Denmark-based biopharmaceutical company's stock by far the biggest gainer listed on major U.S. exchanges, prior to a trading halt. The stock, which was up as much as 1,387% at its intraday high of $77.77, was halted for volatility for the 20th time Thursday at 3:24 p.m. Eastern with the last trade at $25.30, and remains halted. The stock's rally gave the company a market capitalization of $884.3 million. The company confirmed that there was no news released Thursday. The last announcement was May 7, when the company said a pivotal trial of its treatment for Lou Gehrig's disease failed to meet primary and secondary endpoints, sending the stock plunging 32.8% that day. After Orphazyme, the next biggest gainer Thursday was Boston-based biotech Galecto Inc.'s stock undefined, which ran up 170.0% prior to its seventh halt for volatility at 3:15 p.m. The stock's rallies comes as Nasdaq Composite undefined gained 0.8% and the S&P 500 undefined rose 0.5%.

More On MarketWatch

About the Author